Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Exercise/Conversion of 52,744 TEVA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 52,744 | n/a |
| Jun 12, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 25,800 | n/a |
| Mar 9, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 19,654 | n/a |
| Mar 6, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 23,251 | n/a |
| Mar 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 24,900 | n/a |
| Jan 29, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 141,478 | n/a |
| Aug 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 52,742 | n/a |
| Jun 16, 2025 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 30,700 | n/a |
| Mar 7, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 78,616 | n/a |
| Mar 6, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 23,251 | n/a |